Trial intelligence / Profile preview

LIFE Study: Losartan vs Atenolol in Hypertension with LVH

NCT00338260Phase 3Completed

Sponsor
Organon & Co.
Start
Jun 1995
Primary completion
Sep 2001
Modality
Small Molecules
01

Overview

A Phase 3 trial of losartan in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Organon & Co.. Started Jun 1995; status: completed.

02

Drugs

losartan
03

Conditions

hypertension (HTN)left ventricular hypertrophy (LVH)

Beyond the preview

Go deeper on NCT00338260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00338260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call